An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with ...
Activation of certain memory B cells may be driving systemic lupus erythematosus incidence in individuals who had ...
When killer T cells of our immune system divide, they normally undergo asymmetric cell division (ACD): Each daughter cell ...
Kyverna Therapeutics is upgraded to Buy based on strengthened financials and the potential for commercial launch by the end ...
Data from a new mouse model may help advance therapeutic development in celiac disease, including improved TG2 inhibitors and ...
Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before ...
Adaptive Biotechnologies (ADPT) announced two non-exclusive agreements with Pfizer (PFE) to leverage Adaptive’s proprietary T-cell receptor ...
A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritisA data licensing agreement to access ...
A common virus carried by most humans could trigger lupus, offering new clues for preventing and treating this dangerous ...
Research presented December 8 at the American Society of Hematology Conference in Florida, has shown that a new kind of CAR T ...
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, ...
Patients with advanced marginal zone lymphoma (MZL) now have a CAR T-cell therapy with the FDA approval of lisocabtagene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback